Rodon Biologics Receives “Selo ID” Certification for R&D Excellence
Rodon Biologics is proud to announce that we have been awarded the “Selo ID: Reconhecimento de Idoneidade para a Prática de Atividades de I&D” by the Portuguese National Innovation Agency (ANI). This prestigious certification acknowledges our competence in conducting Research and Development (R&D) activities in the areas of biotechnology and health.
The “Selo ID” recognition enhances Rodon Biologics' ability to pursue cutting-edge innovations while offering important benefits for our clients. Specifically, this certification allows companies working with us to apply for the SIFIDE II (Sistema de Incentivos Fiscais em Investigação e Desenvolvimento Empresarial) program, ensuring that service fees related to R&D activities are eligible for tax incentives.
We are honored by this recognition and remain committed to driving innovation in biotechnology and healthcare, fostering impactful collaborations, and contributing to the growth of the sector.
June 06, 2023